Novartis takes home rights to Lubris’ eye drug
admin 7th April 2017 Uncategorised 0Novartis has elected to exercise an option to in-license experimental eye drug ECF843 from US biopharma Lubris.
More: Novartis takes home rights to Lubris’ eye drug
Source: News